These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2447421

  • 1. Cyclic GMP in nicorandil-induced vasodilatation and tolerance development.
    Kukovetz WR, Holzmann S.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S25-30. PubMed ID: 2447421
    [Abstract] [Full Text] [Related]

  • 2. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS, Cantor E, Ho E, Walega M.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [Abstract] [Full Text] [Related]

  • 3. Molecular mechanism of action of nicorandil.
    Kukovetz WR, Holzmann S, Pöch G.
    J Cardiovasc Pharmacol; 1992 Sep; 20 Suppl 3():S1-7. PubMed ID: 1282168
    [Abstract] [Full Text] [Related]

  • 4. Comparative vasorelaxing profiles of nicorandil, isosorbide dinitrate and nitroglycerin in isolated coronary arteries of the dog.
    Ohba Y, Shiraki Y, Sakai K.
    Jpn J Pharmacol; 1987 Nov; 45(3):397-404. PubMed ID: 2963927
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of vasodilation by nitrates: role of cyclic GMP.
    Kukovetz WR, Holzmann S, Romanin C.
    Cardiology; 1987 Nov; 74 Suppl 1():12-9. PubMed ID: 2886220
    [Abstract] [Full Text] [Related]

  • 6. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75).
    Holzmann S.
    J Cardiovasc Pharmacol; 1983 Nov; 5(3):364-70. PubMed ID: 6191133
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of nitrate-induced vasodilatation and tolerance.
    Kukovetz WR, Holzmann S.
    Eur J Clin Pharmacol; 1990 Nov; 38 Suppl 1():S9-14. PubMed ID: 1972361
    [Abstract] [Full Text] [Related]

  • 8. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.
    Kukovetz WR, Holzmann S, Braida C, Pöch G.
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):627-33. PubMed ID: 1711631
    [Abstract] [Full Text] [Related]

  • 9. Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity.
    Henry PJ, Horowitz JD, Louis WJ.
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):365-70. PubMed ID: 1691358
    [Abstract] [Full Text] [Related]

  • 10. Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.
    Meisheri KD, Cipkus-Dubray LA, Hosner JM, Khan SA.
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):903-12. PubMed ID: 1714013
    [Abstract] [Full Text] [Related]

  • 11. Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.
    Jinno Y, Kasai H, Ohta H, Nishikori K, Fukushima H, Ogawa N.
    Br J Pharmacol; 1992 Aug; 106(4):906-9. PubMed ID: 1327392
    [Abstract] [Full Text] [Related]

  • 12. Differences between nitrates: role of isosorbide 2-mononitrate.
    Raddino R, Caretta G, Bonadei I, Teli M, Vizzardi E, Cas LD.
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):486-92. PubMed ID: 20414121
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of nitrate-induced vasodilation and tolerance.
    Kukovetz WR, Holzmann S.
    Z Kardiol; 1983 Jul; 72 Suppl 3():14-9. PubMed ID: 6141677
    [Abstract] [Full Text] [Related]

  • 14. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs.
    Sakai K, Kuromaru O.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 8():S17-24. PubMed ID: 2447420
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of coronary guanylate cyclase by nicorandil (SG-75) as a mechanism of its vasodilating action.
    Schmidt K, Reich R, Kukovetz WR.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Jul; 10(1):43-53. PubMed ID: 2858501
    [Abstract] [Full Text] [Related]

  • 16. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
    Borg C, Mondot S, Mestre M, Cavero I.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors.
    Matsumoto T, Takahashi M, Omura T, Takaoka A, Liu Q, Nakae I, Kinoshita M.
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):772-9. PubMed ID: 9234658
    [Abstract] [Full Text] [Related]

  • 18. Mode of action of nitrates with regard to vasodilatation and tolerance.
    Kukovetz WR, Holzmann S.
    Z Kardiol; 1986 Jun; 75 Suppl 3():8-11. PubMed ID: 2879392
    [Abstract] [Full Text] [Related]

  • 19. Antiplatelet effects of a novel antianginal agent, nicorandil.
    Jaraki O, Strauss WE, Francis S, Loscalzo J, Stamler JS.
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):24-30. PubMed ID: 7511731
    [Abstract] [Full Text] [Related]

  • 20. Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery.
    Endoh M, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):319-21. PubMed ID: 6306488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.